Extent and patterns of methylated CpG sites are similar in GB and IDH wild-type astrocytoma with ptert mutations. In both tumor entities, higher numbers of methylated CpG sites appear to be associated with a more favorable outcome. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).